What is FloShield?
FloShield is at the forefront of enhancing surgical procedures through its advanced laparoscopic vision systems, including FloShield Air and FloShield Plus. The company's proprietary Vortex Barrier Technology is designed to maintain a clear field of vision for surgeons by preventing condensation, debris, and smoke from obscuring laparoscope lenses during operations. This technology is crucial for improving surgical workflow, as it allows for intra-operative lens cleaning without the need to remove the scope. By reducing procedure times and associated costs, FloShield's solutions offer substantial benefits to a wide array of surgical clients, ensuring compatibility with various laparoscopes.
How much funding has FloShield raised?
FloShield has raised a total of $15.5M across 3 funding rounds:
Private Equity
$1.4M
Private Equity
$2M
Series C
$12.1M
Private Equity (2008): $1.4M with participation from Canaan Partners, Charter Life Sciences, and Radius Ventures
Private Equity (2010): $2M led by Radius Ventures, Canaan Partners, and Charter Life Sciences
Series C (2015): $12.1M supported by Canaan Partners and Radius Ventures
Key Investors in FloShield
Radius Ventures
Radius Ventures was a venture capital firm founded in 1997, focused on building innovative companies in the health and life sciences sectors. Over its 27 years of operation, the firm invested in more than 40 venture-stage businesses, many of which achieved successful exits through IPOs or acquisitions.
Canaan Partners
Canaan is an early-stage venture capital firm that invests in technology and healthcare companies, backing founders from seed through growth stages in areas such as enterprise software, fintech, consumer, biopharma, and digital health.
Charter Life Sciences
Charter Life Sciences ("CLS") is a life sciences venture capital firm with offices in Palo Alto, California and Cincinnati, Ohio. CLS focuses on providing the initial venture capital to companies that are developing innovative products for significant unmet medical needs.
What's next for FloShield?
With substantial enterprise-level backing and a recent strategic investment, FloShield is well-positioned for accelerated growth and innovation. The company's focus on improving surgical efficiency and patient outcomes through its advanced vision technology aligns with the increasing demand for minimally invasive procedures. Future strategic initiatives will likely involve expanding its product line, increasing market penetration in key surgical specialties, and potentially exploring new technological advancements to further solidify its leadership in the surgical vision solutions market. The sustained interest from prominent life sciences investors indicates strong confidence in FloShield's business model and its potential to disrupt the surgical equipment landscape.
See full FloShield company page
